Conor Healy, CEO of Cork Chamber said:
“It is very welcome news that Pfizer plans to invest €300million into its Irish operations. The pharmaceutical manufacturer has had a site in Cork since 1969 and is a key investor and employer in the region."
"Pfizer is an important player in enriching the pharmaceutical cluster in Cork, and great credit is due to the management and entire Pfizer team for securing the investment for the construction of a development facility on the Ringaskiddy site to manufacture pharmaceutical compounds for Pfizer’s clinical trials globally."
"Cork continues to grow as a destination for pharma and life sciences investors, a reputation that carries across the globe.”